150 related articles for article (PubMed ID: 34858842)
1. Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma.
Li S; Zhao J; Lv L; Dong D
Front Oncol; 2021; 11():762821. PubMed ID: 34858842
[TBL] [Abstract][Full Text] [Related]
2. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
3. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
6. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
7. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
8. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
9. Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.
Zheng Y; Liu Y; Zhao S; Zheng Z; Shen C; An L; Yuan Y
Cancer Manag Res; 2018; 10():6079-6096. PubMed ID: 30538557
[TBL] [Abstract][Full Text] [Related]
10. SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma
Li G; Shen Q; Xu H; Zhou Y; Li C; Li Y; He M
Front Oncol; 2023; 13():1138995. PubMed ID: 37081987
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Six Gene Prognosis Signature for Papillary Thyroid Cancer Using Multi-Omics Methods and Bioinformatics Analysis.
Ren H; Liu X; Li F; He X; Zhao N
Front Oncol; 2021; 11():624421. PubMed ID: 33816258
[TBL] [Abstract][Full Text] [Related]
12. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
13. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
Yang L; Yin W; Liu X; Li F; Ma L; Wang D; Li H
PeerJ; 2021; 9():e11273. PubMed ID: 33986994
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
15. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract][Full Text] [Related]
17.
Sun Y; Zhang Z
Genet Test Mol Biomarkers; 2020 May; 24(5):296-308. PubMed ID: 32384023
[No Abstract] [Full Text] [Related]
18. Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.
Guo J; Li W; Cheng L; Gao X
Int J Gen Med; 2022; 15():3933-3941. PubMed ID: 35431572
[TBL] [Abstract][Full Text] [Related]
19. Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.
Zhu Q; Sun Y; Zhou Q; He Q; Qian H
Mol Clin Oncol; 2018 Dec; 9(6):597-606. PubMed ID: 30546887
[TBL] [Abstract][Full Text] [Related]
20. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
